Collect evidence from a single real world study or across an entire ecosystem of high-quality networks. IQVIA's data sources come from relationships with hospitals, registries, healthcare providers and others groups around the world, including
IQVIA provides customers with a connected network infrastructure by aggregating databases and supporting federated data networks. We then apply advanced analytics and expert insight to enable customized filtering to support your specific research and commercialization goals.
You can now more efficiently research and develop precision medicines targeted to smaller populations. Innovative study designs use real world evidence to supplement primary data collection and deliver savings in the range of 60-80%. Our evidence networks increase the availability of data to support these hard-to-find populations.
Our evidence networks include self-reported studies, where patients can report outcomes directly without physician involvement. And enriched studies, where secondary data is combined with study-specific primary data. These and other methods provide faster, more cost-efficient study design options that regulators increasingly recognize as valid.
The Collaboration for Oncology Data in Europe (CODE) seeks to expand our knowledge of anti-cancer medicine use through a dedicated oncology data network.
Access a dedicated network of European cancer hospitals to capture real world data that reflects the latest clinical practice and perform oncology studies faster.
IQVIA brings together data that is constantly refreshed and harmonized while pulling in new data to increase the overall clinical richness. The data stays secure at the site but puts insights at your fingertips. Our library of algorithms and machine learning capabilities power analytics to create rich, aggregated outputs that include
Learn more about the federated evidence networks and massive, non-identified global databases that inform our real world solutions.
Use emerging data sources and advances in evidence methods to demonstrate product value and safety.